En savoir plus
Primary lung tumors are now a global health problem. The incidence has risen dramatically during the last 5--6 decades, reflecting the popularity of cigarette smoking.
In this, the fifth volume dealing with lung cancer in the series KappaCANCER TREATMENT AND RESEARCHkappa, many current research topics are covered by notable authorities, including chemoprevention, growth factors, multidrug resistance, new agents, and haematopoietic growth factors.
Altogether, the 17 chapters from twelve countries highlight some of the rapid developments taking place in basic and clinical research of lung cancer. These chapters not only give up-to-date information, they will also stimulate further research into this man-made disease which was almost unheard of a century ago.
Table des matières
1. Tobacco consumption and lung cancer.- 2. Lung cancer chemoprevention.- 3. Smoking cessation programs.- 4. Genetics of lung cancer: implications for early detection and prevention.- 5. Growth factors and lung cancer.- 6. The development and progression of adenocarcinoma of the lung.- 7. Neuroendocrine characteristics in malignant lung tumors: implications for diagnosis, treatment, and prognosis.- 8. In vivo models for testing of cytostatic agents in non-small cell lung cancer.- 9. In vitro models for testing of cytostatic agents in small cell lung cancer.- 10. Multidrug resistance in lung cancer.- 11. New techniques in the diagnosis and staging of lung cancer.- 12. The role of chest irradiation in small cell lung cancer.- 13. The role of hematopoietic growth factors in small cell lung cancer: a review.- 14. Interferon and lung cancer.- 15. New antineoplastic agents in lung cancer 1988-1993.- 16. Pulmonary blastomas.- 17. Psychosocial issues in lung cancer patients.
